NCT06943833 2026-01-20
IVOLGA
AstraZeneca
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT03612791 2025-06-03
ATEZOLACC
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed
NCT06916117 2025-04-08
Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC
RenJi Hospital
Phase 2 Not yet recruiting
NCT05687851 2024-09-19
Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Phase 2 Recruiting
NCT06055738 2023-09-28
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
Tang-Du Hospital
Phase 2 Recruiting
NCT05437692 2022-10-12
Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT04238988 2021-08-27
MITO CERV 3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Unknown
NCT04884906 2021-05-13
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT02045433 2020-08-21
Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer
University of Texas Southwestern Medical Center
Phase 2 Terminated